The paper, published by the American Journal of Managed Care, concludes that 2004 Medicare reforms that transitioned in-center hemodialysis care payments from a capitated to a tiered fee-for-service model may have discouraged use of home dialysis — which is more flexible and convenient for patients — by making in-center options more lucrative for physicians.
To come to this conclusion, the authors compared patients with traditional Medicare to those with Medicare Advantage, which was not affected by the policy. They also examined patient proximity to large dialysis facilities, because larger facilities offer an opportunity for physicians to increase in-center dialysis revenues for a lower cost.
They found those most affected by the policy change were patients living near large dialysis facilities. Those patients experienced a 0.9 percent reduction in absolute probability of home dialysis after the payment reforms, compared to patients in areas with smaller facilities.
“These findings highlight both an area of policy failure and the importance of considering unintended consequences of future efforts to reform physician payment,” the authors wrote.
More articles on finance:
NC budget gives recently shuttered hospital chance to reopen
Law firm fined over medical debt collection practices
10 costliest medical conditions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
